2024 Spain Drugs of Abuse Testing Market for 12 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

August 2024 | | ID: 2F6FF72EAEC3EN
Venture Planning Group

Abstracts

This new 260-page report from LeadingMarketResearch.com provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report is available by section, and can be customized to specific information needs and budget.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.Contains 260 pages and 10 tables

Contents

Introduction
Worldwide Market and Technology Overview
A. Major Drugs of Abuse

1. OVERVIEW

2. TEST METHODOLOGIES

3. AMPHETAMINES

4. ANTIDEPRESSANTS

5. BARBITURATES

6. BENZODIAZEPINES

7. CANNABINOIDS/MARIJUANA

8. COCAINE

9. LYSERGIC ACID DIETHYLAMIDE (LSD)

10. METHADONE

11. METHAQUALONE

12. OPIATES

13. PHENCYCLIDINE

14. PROPOXPHENE

B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers.
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications

1. MONOCLONAL AND POLYCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

3. TANDEM MASS SPEC

4. IT AND AUTOMATION

5. DRY CHEMISTRY

6. BIOSENSORS

D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS

5. EMERGING SUPPLIERS

6. MAJOR TYPES OF DISTRIBUTORS

7. MARKET SEGMENTATION

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges